Cargando…
Can the personalized medicine approach contribute in controlling tuberculosis in general and India in particular?
Poor drug compliance and drug-resistant Mycobacterium tuberculosis are the two principal obstacles in controlling tuberculosis (TB) in endemic regions including India, which has contributed the most to global TB burden. We argue here that a personalized medicine approach, to start with the N-acetyl...
Autores principales: | Khan, Nikhat, Das, Aparup |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8982531/ https://www.ncbi.nlm.nih.gov/pubmed/35694414 http://dx.doi.org/10.1093/pcmedi/pbaa021 |
Ejemplares similares
-
Molecular surveillance of anti-malarial drug resistance genes in Plasmodium falciparum isolates in Odisha, India
por: Rana, Ramakanta, et al.
Publicado: (2022) -
Personalized medicine for rare neurogenetic disorders: can we make it happen?
por: van Eeghen, Agnies M., et al.
Publicado: (2022) -
Nosocomial Tuberculosis in India
por: Pai, Madhukar, et al.
Publicado: (2006) -
Controlling the drug-resistant tuberculosis epidemic in India: challenges and implications
por: Husain, Aliabbas A., et al.
Publicado: (2021) -
Optimal management of drug-resistant tuberculosis: Can India lead the way?
por: Masini, Tiziana, et al.
Publicado: (2023)